Literature DB >> 17381454

Factors associated with a high tumour thickness in patients with melanoma.

J Baumert1, G Plewig, M Volkenandt, M-H Schmid-Wendtner.   

Abstract

BACKGROUND: Prognosis of patients with melanoma is strongly associated with tumour thickness at time of diagnosis. Therefore, knowledge of patient characteristics and behaviour associated with a high tumour thickness is essential for the development and improvement of melanoma prevention campaigns.
OBJECTIVES: The present study aimed to identify sociodemographic, clinical and behavioural factors associated with high tumour thickness according to Breslow.
METHODS: The study population consisted of 217 patients with histologically proven primary invasive cutaneous melanomas seen at the Department of Dermatology and Allergology at the Ludwig-Maximilian-University Munich, Germany, between January 1999 and January 2001. Personal interviews were conducted by two physicians to obtain information on sociodemographic characteristics and on patients' knowledge of melanoma symptoms, sun behaviour, delay in diagnosis and related factors. Multivariate linear and logistic regression analysis with stepwise variable selection was used to identify risk groups with a high tumour thickness. To assess possible effect modifications, interaction terms were included in the regression analysis.
RESULTS: The median tumour thickness was 0.8 mm (interquartile range 0.5-1.6). Fifty-seven patients (26%) had tumour thickness >1.5 mm. In a multivariate linear regression analysis, patients living alone and patients with a low educational level showed a significantly greater tumour thickness. The relation of melanoma knowledge to tumour thickness was modified by the melanoma subtype: whereas lack of melanoma knowledge led to an increased tumour thickness for the subtypes superficial spreading melanoma, lentigo maligna melanoma and unspecified malignant melanoma, no significant effect was estimated for the subtypes nodular melanoma (NM) and acrolentiginous melanoma (ALM). Sex, age, self-detection of melanoma, patient delay and professional delay were not significantly associated with the tumour thickness in multivariate linear regression. Similar results were found in multivariate logistic regression.
CONCLUSIONS: An increased tumour thickness was found in subjects living alone and having a low educational level. These subjects should be targeted in future prevention campaigns in a more focused way. Further efforts are necessary to improve knowledge and earlier detection of melanoma subtypes NM and ALM.

Entities:  

Mesh:

Year:  2007        PMID: 17381454     DOI: 10.1111/j.1365-2133.2007.07805.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

1.  The influence of dermatologist and primary care physician visits on melanoma outcomes among Medicare beneficiaries.

Authors:  Richard G Roetzheim; Ji-Hyun Lee; Jeanne M Ferrante; Eduardo C Gonzalez; Ren Chen; Kate J Fisher; Kymia Love-Jackson; Ellen P McCarthy
Journal:  J Am Board Fam Med       Date:  2013 Nov-Dec       Impact factor: 2.657

2.  Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.

Authors:  Michael Lattanzi; Yesung Lee; Danny Simpson; Una Moran; Farbod Darvishian; Randie H Kim; Eva Hernando; David Polsky; Doug Hanniford; Richard Shapiro; Russell Berman; Anna C Pavlick; Melissa A Wilson; Tomas Kirchhoff; Jeffrey S Weber; Judy Zhong; Iman Osman
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

3.  The role of spatially-derived access-to-care characteristics in melanoma prevention and control in Los Angeles county.

Authors:  Loraine A Escobedo; Ashley Crew; Ariana Eginli; David Peng; Michael R Cousineau; Myles Cockburn
Journal:  Health Place       Date:  2017-04-06       Impact factor: 4.078

4.  Factors Related to Delayed Diagnosis of Cutaneous Melanoma in the Brazilian Public Health System.

Authors:  Ana Paula Bhering Nogueira; Ana Paula Drummond-Lage; Gustavo Drummond Pinho Ribeiro; Estevão Ferreira Leite; Marcus Henrique Xavier; Alberto Julius Alves Wainstein
Journal:  J Cancer Educ       Date:  2022-05-17       Impact factor: 1.771

5.  Changes in the presentation of nodular and superficial spreading melanomas over 35 years.

Authors:  Melanie A Warycha; Paul J Christos; Madhu Mazumdar; Farbod Darvishian; Richard L Shapiro; Russell S Berman; Anna C Pavlick; Alfred W Kopf; David Polsky; Iman Osman
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

6.  Development of a practical guide for the early recognition for malignant melanoma of the foot and nail unit.

Authors:  Ivan R Bristow; David Ar de Berker
Journal:  J Foot Ankle Res       Date:  2010-09-28       Impact factor: 2.303

7.  Phenotypic Characteristics and Melanoma Thickness in Women.

Authors:  Reza Ghiasvand; Adèle C Green; Torkjel M Sandanger; Elisabete Weiderpass; Trude E Robsahm; Marit B Veierød
Journal:  Acta Derm Venereol       Date:  2021-04-29       Impact factor: 3.875

8.  Dermoscopy as a technique for the early identification of foot melanoma.

Authors:  Ivan R Bristow; Jonathan Bowling
Journal:  J Foot Ankle Res       Date:  2009-05-12       Impact factor: 2.303

9.  A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world.

Authors:  Mary Jane Sneyd; Brian Cox
Journal:  BMC Cancer       Date:  2013-08-06       Impact factor: 4.430

10.  Increasing melanoma awareness among health and social care professionals in secondary care in an era of reduced skin cancer referrals due to COVID-19.

Authors:  C Quinlan; R Gill; M Murphy
Journal:  Clin Exp Dermatol       Date:  2020-07-22       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.